|
|
||||||||
The Annals of Thoracic Surgery, Vol 47, 809-815, Copyright © 1989 by The Society of Thoracic Surgeons
SF Bolling, LE Bies, KP Gallagher and EL Bove
This study was undertaken to investigate whether adenosine administered
during cardioplegic arrest could enhance myocardial protection and improve
recovery of function after ischemia. Isolated perfused rabbit hearts were
subjected to 120 minutes of hypothermic (32 degrees C) multidose
cardioplegia-induced ischemia. Control hearts (n = 23) received modified
St. Thomas's cardioplegia, and the remaining hearts received cardioplegia
with either 100 microM (n = 11), 200 microM (n = 11), or 400 microM (n =
11) adenosine. After ischemia and 45 minutes of reperfusion, left
ventricular contractility was superior in all groups of adenosine-treated
hearts compared with control hearts. Furthermore, there was a significant
incremental increase in functional recovery with increasing dose of
adenosine. Postischemic diastolic stiffness was significantly better in all
adenosine groups compared with controls. No differences were noted in
coronary flow or myocardial water content between adenosinetreated and
control hearts. These data demonstrate that adenosine administered in these
concentrations provides myocardial protection and improved recovery of both
systolic and diastolic function after global ischemia, presumably
metabolically by reducing depletion of adenosine triphosphate or enhancing
repletion of adenosine triphosphate and enabling improved postischemic
recovery.
ARTICLES
Enhanced myocardial protection with adenosine
Section of Thoracic Surgery, University of Michigan Medical Center, Ann Arbor 48109.
This article has been cited by other articles:
![]() |
B. G. Fogelson, S. I. Nawas, and W. R. Law MECHANISMS OF MYOCARDIAL PROTECTION BY ADENOSINE-SUPPLEMENTED CARDIOPLEGIC SOLUTION: MYOFILAMENT AND METABOLIC RESPONSES J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 601 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Spinale Cellular and molecular therapeutic targets for treatment of contractile dysfunction after cardioplegic arrest Ann. Thorac. Surg., November 1, 1999; 68(5): 1934 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vinten-Johansen, V. H. Thourani, R. S. Ronson, J. E. Jordan, Z.-Q. Zhao, M. Nakamura, D. Velez, and R. A. Guyton Broad-spectrum cardioprotection with adenosine Ann. Thorac. Surg., November 1, 1999; 68(5): 1942 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L Zarro, D. A Palanzo, and F. S Sadr Myocardial preconditioning using adenosine: review and clinical experience Perfusion, March 1, 1998; 13(2): 145 - 150. [Abstract] [PDF] |
||||
![]() |
M. H. Cox, S.-J. O, L. Hebbar, R. Mukherjee, F. A. Crawford Jr, and F. G. Spinale Protective Effects of Adenosine on Myocyte Contractility During Cardioplegic Arrest Ann. Thorac. Surg., April 1, 1997; 63(4): 981 - 987. [Abstract] [Full Text] |
||||
![]() |
O. Katayama, S. J. M. Ledingham, M. Amrani, R. T. Smolenski, D. R. Lachno, J. Jayakumar, and M. H. Yacoub Functional and Metabolic Effects of Adenosine in Cardioplegia: Role of Temperature and Concentration Ann. Thorac. Surg., February 1, 1997; 63(2): 449 - 454. [Abstract] [Full Text] |
||||
![]() |
A. K. Pridjian, E. D. Frohlich, C. H. VanMeter, P. M. McFadden, and J. L. Ochsner Pharmacologic Support With High-Energy Phosphate Preservation in the Postischemic Neonatal Heart Ann. Thorac. Surg., June 1, 1995; 59(6): 1435 - 1440. [Abstract] [Full Text] |
||||
![]() |
R. D. Lasley and R. M. Mentzer Jr. The role of adenosine in extended myocardial preservation with the University of Wisconsin solution J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1356 - 1363. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |